...while fast-tracking candidate vaccines represents a positive step forward in the race to stop these outbreaks and to improve global health security, it raises an important question. If vaccine candidates already existed for both of these viruses before the outbreaks began, then why weren’t investigational stockpiles of vaccine ready to go when the first cases were detected?
Although most of the people who died got one or more prompt treatments and intensive care, nearly a quarter had delays of three to seven weeks from diagnosis to treatment, and two got no treatment for mpox.
The U.N. health agency said in a statement Monday that mpox was its new preferred name for monkeypox, saying that both monkeypox and mpox would be used for the next year while the old name is phased out.
Researchers at the U.K. Health Security Agency estimated that one dose of the vaccine was 78% effective at protecting against infection 14 or more days after vaccination.